Effect of Timing of Gonadotropin-Releasing Hormone Agonist Administration for Ovarian Protection in Patients with Breast Cancer.
Conclusion: There was no difference in the ovarian protective effect according to the difference in the timing of administration of GnRHa.
PMID: 32595989 [PubMed]
Source: Journal of Breast Cancer - Category: Cancer & Oncology Tags: J Breast Cancer Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hormones | Ovarian Cancer | Ovaries | Polycystic Ovary Syndrome | Reproduction Medicine | Statistics | Study